HF
MXCT icon

HRT Financial’s MaxCyte MXCT Stock Holding History

HRT Financial’s Portfolio MXCT Stock Details MXCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$20K Sell
28,800
-99,912
-78% -$93.3K ﹤0.01% 3574
2025
Q4 		$199K Buy
+128,712
New +$206K ﹤0.01% 2640
2025
Q3 		– Sell
-37,497
Closed -$81K – 3389
2025
Q2 		$81K Buy
37,497
+20,595
+122% +$49.9K ﹤0.01% 2241
2025
Q1 		$46K Sell
16,902
-109,343
-87% -$431K ﹤0.01% 2246
2024
Q4 		$525K Buy
+126,245
New +$477K ﹤0.01% 1412
2023
Q2 		– Sell
-16,883
Closed -$83K – 2974
2023
Q1 		$83K Buy
+16,883
New +$83.1K ﹤0.01% 2086

Other funds holding MXCT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CFM
Capricorn Fund Managers London, United Kingdom $1.27B AUM 70.17% 1-Year Est. Return
VP
Vitruvian Partners London, United Kingdom $112M AUM 2.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
MA
Mudita Advisors London, United Kingdom $490M AUM 66.64% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BFM
Brooklands Fund Management London, United Kingdom $88.9M AUM

HRT Financial's MXCT Position: Q1 2026 in Review

HRT Financial reduced its MaxCyte (MXCT) stake by 78% in Q1 2026, selling an estimated $93.3K and leaving 28,800 shares worth $20K. The position accounts for ﹤0.01% of the portfolio, ranked #3574.

HRT Financial first reported a position in MXCT in Q1 2023 and has held it in 6 quarters since. The position peaked at $525K in Q4 2024. 130 funds tracked by Wall St. Rank hold MXCT as of Q1 2026.

  • HRT Financial held 28,800 shares of MaxCyte worth $20K as of Q1 2026.
  • HRT Financial sold 99,912 MaxCyte shares in Q1 2026, an estimated $93.3K.
  • MaxCyte made up ﹤0.01% of HRT Financial's portfolio in Q1 2026, its #3574 holding.
  • HRT Financial first reported a position in MaxCyte in Q1 2023 and has held it in 6 quarters since.
  • HRT Financial's MaxCyte position peaked at $525K in Q4 2024.
  • 130 funds tracked by Wall St. Rank held MaxCyte as of Q1 2026.

Based on HRT Financial's 13F filing for Q1 2026, filed 14 May 2026.